Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
Erosive pustular dermatosis of the scalp Indication Strategy Report 2026: IL-17, Trials and Deals
3 August 2026
2026 Erosive pustular dermatosis of the scalp indication strategy covering epidemiology, IL-17 biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Perifolliculitis capitis abscedens et suffodiens Indication Strategy Report 2026: TNF, Trials and Deals
3 August 2026
2026 Perifolliculitis capitis abscedens et suffodiens indication strategy covering epidemiology, TNF biology, active trials, transactions, unmet need,…
Latest Hotspot
8 min read
Acne fulminans Indication Strategy Report 2026: IL-1, Trials and Deals
3 August 2026
2026 Acne fulminans indication strategy covering epidemiology, IL-1 biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Hidradenitis suppurativa Hurley stage III Indication Strategy Report 2026: IL-17, Trials and Deals
3 August 2026
2026 Hidradenitis suppurativa Hurley stage III indication strategy covering epidemiology, IL-17 biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Papillon-Lefevre syndrome Indication Strategy Report 2026: CTSC, Trials and Deals
3 August 2026
2026 Papillon-Lefevre syndrome indication strategy covering epidemiology, CTSC biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Pachyonychia congenita Indication Strategy Report 2026: KRT6A, Trials and Deals
3 August 2026
2026 Pachyonychia congenita indication strategy covering epidemiology, KRT6A biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Olmsted syndrome Indication Strategy Report 2026: TRPV3, Trials and Deals
3 August 2026
2026 Olmsted syndrome indication strategy covering epidemiology, TRPV3 biology, active trials, transactions, unmet need, competition and market attractiveness.
Latest Hotspot
8 min read
Palmoplantar keratoderma Indication Strategy Report 2026: KRT9, Trials and Deals
3 August 2026
2026 Palmoplantar keratoderma indication strategy covering epidemiology, KRT9 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Keratoderma blennorrhagicum Indication Strategy Report 2026: IL-17, Trials and Deals
3 August 2026
2026 Keratoderma blennorrhagicum indication strategy covering epidemiology, IL-17 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Epidermolytic ichthyosis Indication Strategy Report 2026: KRT10, Trials and Deals
3 August 2026
2026 Epidermolytic ichthyosis indication strategy covering epidemiology, KRT10 biology, active trials, transactions, unmet need, competition and market…
Latest Hotspot
8 min read
Congenital ichthyosiform erythroderma Indication Strategy Report 2026: ALOX12B, Trials and Deals
3 August 2026
2026 Congenital ichthyosiform erythroderma indication strategy covering epidemiology, ALOX12B biology, active trials, transactions, unmet need, competition and…
Latest Hotspot
8 min read
Peeling skin syndrome Indication Strategy Report 2026: CDSN, Trials and Deals
3 August 2026
2026 Peeling skin syndrome indication strategy covering epidemiology, CDSN biology, active trials, transactions, unmet need, competition and market attractiveness.